Literature DB >> 15734737

Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner.

Yu Wang1, Karen S L Lam, Jian Yu Xu, Gang Lu, Lance Yi Xu, Garth J S Cooper, Aimin Xu.   

Abstract

Adiponectin, an adipocyte-specific secretory protein, is present in serum as three oligomeric complexes. Apart from its roles as an anti-diabetic and anti-atherogenic hormone, adiponectin has been implicated as an important regulator of cell growth and tissue remodeling. Here we show that some of these functions might be mediated by the specific interactions of adiponectin with several important growth factors. Among six different growth factors examined, adiponectin was found to bind with platelet-derived growth factor BB (PDGF-BB), basic fibroblast growth factor (FGF), and heparin-binding epidermal growth factor-like growth factor (HB EGF) with distinct affinities. The bindings of adiponectin with these growth factors are oligomerization-dependent. PDGF-BB bound to the high molecular weight (HMW) and middle molecular weight (MMW) complexes, but not to the low molecular weight (LMW) complex of adiponectin. Basic FGF preferentially interacted with the HMW form, whereas HB EGF bound to all three forms with comparable affinities. These three growth factors did not compete with each other for their bindings to adiponectin, suggesting the involvement of distinct binding sites. The interactions of adiponectin with PDGF-BB, basic FGF, and HB EGF precluded the bindings to their respective membrane receptors and attenuated the DNA synthesis and cell proliferation induced by these growth factors. Small interfering RNA-mediated down-regulation of adiponectin receptors did not affect the suppressive effects of adiponectin on cell proliferation stimulated by these growth factors. These data collectively suggest that the oligomeric complexes of adiponectin can modulate the biological actions of several growth factors by controlling their bioavailability at a pre-receptor level and that this effect might partly account for the anti-atherogenic, anti-angiogenic, and anti-proliferative functions of adiponectin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734737     DOI: 10.1074/jbc.M501149200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  120 in total

1.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.

Authors:  Meiqian Weng; Michael J Raher; Patricio Leyton; Terry P Combs; Philipp E Scherer; Kenneth D Bloch; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-12       Impact factor: 6.914

2.  The oligomeric structure of high molecular weight adiponectin.

Authors:  Shinji Suzuki; Elizabeth M Wilson-Kubalek; David Wert; Tsu-Shuen Tsao; David H Lee
Journal:  FEBS Lett       Date:  2007-01-30       Impact factor: 4.124

Review 3.  Relationships between fat and bone.

Authors:  I R Reid
Journal:  Osteoporos Int       Date:  2007-10-27       Impact factor: 4.507

Review 4.  Adipose tissue: the new endocrine organ? A review article.

Authors:  Susan E Wozniak; Laura L Gee; Mitchell S Wachtel; Eldo E Frezza
Journal:  Dig Dis Sci       Date:  2008-12-04       Impact factor: 3.199

5.  Adiponectin attenuates liver fibrosis by inducing nitric oxide production of hepatic stellate cells.

Authors:  Zhixia Dong; Lin Su; Saeed Esmaili; Tristan J Iseli; Mehdi Ramezani-Moghadam; Liangshuo Hu; Aimin Xu; Jacob George; Jianhua Wang
Journal:  J Mol Med (Berl)       Date:  2015-07-09       Impact factor: 4.599

6.  Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line.

Authors:  Peter C Konturek; Grzegorz Burnat; Tilman Rau; Eckhart G Hahn; Stanislaw Konturek
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

Review 7.  Obesity, energy balance, and cancer: new opportunities for prevention.

Authors:  Stephen D Hursting; John Digiovanni; Andrew J Dannenberg; Maria Azrad; Derek Leroith; Wendy Demark-Wahnefried; Madhuri Kakarala; Angela Brodie; Nathan A Berger
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-03

8.  Adiponectin deficiency does not affect development and progression of spontaneous colitis in IL-10 knockout mice.

Authors:  Maria Pini; Melissa E Gove; Raja Fayad; Robert J Cabay; Giamila Fantuzzi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-12       Impact factor: 4.052

9.  Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk.

Authors:  Virginia G Kaklamani; Maureen Sadim; Alex Hsi; Kenneth Offit; Carole Oddoux; Harry Ostrer; Habibul Ahsan; Boris Pasche; Christos Mantzoros
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

Review 10.  Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies.

Authors:  Nikolaos Spyrou; Konstantinos I Avgerinos; Christos S Mantzoros; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.